CD8A and cancer: For example, Kudo (2019b) found that activated CD8+ T cells released interferon gamma (IFN-γ) during the process of initial cellular immunity, which not only attacked tumor cells but also engaged with receptors on the surface of cancer cells to upregulate PD-L1 and inhibit antitumor effects.